NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,431,572 | -15.3% | 20,592 | +0.9% | 0.00% | +50.0% |
Q1 2022 | $1,690,070 | +164.5% | 20,400 | +270.9% | 0.00% | 0.0% |
Q3 2021 | $639,000 | -73.8% | 5,500 | -50.0% | 0.00% | -50.0% |
Q2 2021 | $2,440,000 | +9.9% | 11,000 | -34.5% | 0.00% | -42.9% |
Q1 2021 | $2,221,000 | -80.1% | 16,800 | -74.0% | 0.01% | -80.0% |
Q4 2020 | $11,178,000 | +144.9% | 64,600 | +57.6% | 0.04% | +118.8% |
Q3 2020 | $4,564,000 | +317.9% | 41,000 | +122.8% | 0.02% | +700.0% |
Q2 2020 | $1,092,000 | -70.5% | 18,400 | -66.5% | 0.00% | -77.8% |
Q1 2020 | $3,704,000 | -60.4% | 55,000 | -50.5% | 0.01% | -52.6% |
Q4 2019 | $9,354,000 | -19.3% | 111,000 | -28.4% | 0.02% | -17.4% |
Q3 2019 | $11,590,000 | +45.9% | 155,000 | +23.4% | 0.02% | +43.8% |
Q2 2019 | $7,942,000 | +144.7% | 125,600 | +86.4% | 0.02% | +23.1% |
Q1 2019 | $3,246,000 | +108.9% | 67,400 | +45.3% | 0.01% | +85.7% |
Q4 2018 | $1,554,000 | +86.6% | 46,400 | +191.8% | 0.01% | +133.3% |
Q3 2018 | $833,000 | +8.2% | 15,900 | -35.4% | 0.00% | 0.0% |
Q2 2018 | $770,000 | +43.7% | 24,600 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $536,000 | – | 24,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |